D.C. Act 26-416 · Section 5012
Section 5012 (no heading in source)
Before/After explanation not reviewed yet. The official section text is available below; a legal comparison will be added only after source review.
Enacted 2026-08-13 · Effective 2026-08-13 · Emergency act.
Historical enacted record. Complete current-law and later-development review may be unfinished.
Official section text
5012 Section 4907b of the Department of Health Functions Clarification Act of 2001, effective February 26, 2015 (D.C. Law 20-155; D.C. Official Code § 7-736.02), is amended as follows: (a) The section heading is amended to read as follows: 4907b AIDS Drug Assistance Program Fund. . (b) Subsection (a) is amended by striking the phrase "Communicable and Chronic Disease Prevention and Treatment Fund" and inserting the phrase "AIDS Drug Assistance Program Fund" in its place. (c) Subsections (b), (c), and (d) are amended to read as follows: (b) Revenue from the following sources shall be deposited into the Fund: (1) Rebates provided by pharmaceutical companies to the District pursuant to section 340B of the Public Health Service Act, approved November 4, 1992 (106 Stat. 4967; 42 U.S.C. § 256b), for medications included in the AIDS Drug Assistance Program ("ADAP") formulary; and (2) Insurance refunds and excess premium tax credits recovered by the District from ADAP program participants. (c) Money in the Fund shall be used to administer ADAP, including the procurement of HIV/AIDS medications and the provision of HIV care and services for eligible District residents, and for the fulfillment of federal grant-matching requirements for ADAP. (d) (1) The money deposited into the Fund but not expended in a fiscal year shall not revert to the unassigned fund balance of the General Fund of the District of Columbia at the end of a fiscal year, or at any other time. (2) Any money in the Communicable and Chronic Disease Prevention and Treatment Fund as of September 30, 2026 shall be considered part of the Fund. .